PG13 Challenges in the treatment of tuberculosis
Postgraduate CourseChairs: J. Heyckendorf (Hamburg, Germany), R. Duarte (Porto, Portugal)
Aims: Access educational materials here To help clinicians to confidently manage all tuberculosis patients with the aim of achieving tuberculosis elimination in Europe and elsewhere; to help clinicians treat tuberculosis in patients with whom failure of treatment or adherence could result in drug resistance; and to address concerns regarding heart rate-corrected QT interval (QTc) prolongation with current second-line drugs.
Diagnosing and treating paediatric tuberculosis infections F. Brinkmann (Bochum, Germany)
| |
Treating multiple-drug resistant tuberculosis L. Guglielmetti (Paris, France)
| |
Treating tuberculosis in patients with comorbidities R. van Hest (Groningen, Netherlands)
| |
Treating acute complications and the severely ill patient with tuberculosis G. Hagan (Solihull (West Midlands), United Kingdom)
| |
Group assignment F. Brinkmann (Bochum, Germany), L. Guglielmetti (Paris, France), R. van Hest (Groningen, Netherlands), G. Hagan (Solihull (West Midlands), United Kingdom)
| |